Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Conditions
- Estrogen Receptor-negative Breast Cancer
- Progesterone Receptor-negative Breast Cancer
- Recurrent Breast Cancer
- Stage IV Breast Cancer
Interventions
- DRUG: Medroxyprogesterone progesterone acetate (MPA)
- DRUG: Medroxyprogesterone with Cyclophosphamide + Methotrexate
Sponsor
Indiana University
Collaborators